Abstract
Objectives: Thoracic aortic infections are a deadly disease. Homografts are considered the gold standard to replace the affected aorta. However, availability is limited and long term results may be limited by homograft degeneration. Pericardial tube grafts have been suggested as an alternative. Biological valved pericardial conduits are commercially available. We reviewed our data on pericardial tube graft implantations.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
